The PML protein is associated to nuclear bodies (NBs) whose functions are as yet unknown. PML and two other NBs-associated proteins, Sp100 And ISG20 are directly induced by interferons (IFN). PML and Sp100 proteins are covalently linked to SUMO-1, and ubiquitin-like peptide. PML NBs are disorganized in acute promyelocytic leukemia and during several DNA virus infections. In particular, the HSV-1 ICP0 protein is known to delocalize PML from NBs. Thus, NBs could play an important role in oncogenesis, IFN response and viral infections. Here, we show that HSV-1 induced PML protein degradation without altering its mRNA level. This degradation was time-and multiplicity of infectiondependent. Sp100 protein was also degraded, while another SUMO-1 conjugated protein, RanGAP1 and the IFN-induced protein kinase PKR were not. The proteasome inhibitor MG132 abrogated the HSV-1-induced PML and Sp100 degradation and partially restored their NB-localization. HSV-1 induced PML and Sp100 degradation constitutes a new example of viral inactivation of IFN target gene products.
Introduction PML (Pro-Myelocytic Leukemia) belongs to a family of nine proteins de®ned by the presence of a C3HC4 (RING ®nger) zinc binding motif , one or two other cysteine-rich motifs, the B boxes, as well as a very long coiled-coil region (Reddy et al., 1992) implicated in homo-and heterodimerization (Kastner et al., 1992; Perez et al., 1993) . PML has a speckled nuclear expression pattern as a consequence of its localization on nuclear bodies (NBs) (Daniel et al., 1993; Dyck et al., 1994; Koken et al., 1994; Weis et al., 1994) . The PML gene was originally identi®ed through its fusion to the RARa gene in the t(15;17) translocation found in acute promyelocytic leukaemia (APL) (de TheÂ et al., 1990; Goddard et al., 1991; Kakizuk et al., 1991; Pandol® et al., 1992) . In APL, the chimeric PML-RARa protein alters the normal localization of PML from the punctuate nuclear patterns to microdispersed tiny dots. Treatment of the APL cells with either retinoic acid or arsenic trioxide leads to degradation of PML-RARa and restoration of the normal localization of NBsassociated proteins (Dyck et al., 1994; Koken et al., 1994; Weis et al., 1994; Yoshida et al., 1996; Zhu et al., 1997) . PML colocalizes on these structures with an autoantigen of primary biliary cirrhosis, Sp100 (Szostecki et al., 1990) and ISG20 (Gongora et al., 1997) . Both PML and Sp100 contain functional IFNa/ b-stimulated response elements ISRE and IFNgactivation sites, GAS (GroÈ tzinger et al., 1996b; Stadler et al., 1995) revealing that PML and Sp100, like ISG20, are primary target genes for IFNs (Campbell et al., 1994; Chelbi-Alix et al., 1995 , Gongora et al., 1997 GroÈ tzinger et al., 1996a; Guldner et al., 1992; Stadler et al., 1995) . The direct induction of the three NBs-associated proteins PML, Sp100 and ISG20 by IFN, suggests a role for this nuclear structure in the IFN response. A protein directly interacting with PML, named PML interacting clone 1, PIC-1 (now renamed SUMO-1 for small ubiquitin-related modi®er) (Boddy et al., 1996) , appears to be localized on NBs. Covalent modi®cations of PML and Sp100 by SUMO-1 has been described (Muller et al., 1998; Sternsdorf et al., 1997b) . Moreover, a cellular ubiquitin-speci®c protease, the herpes virus-associated ubiquitin-speci®c protease (HAUSP) (Everett et al., 1997) has recently been reported to be at least partially NB-associated.
The function of the IFN-induced NBs-associated proteins is yet unknown. We and others have shown that PML has transformation-and growth-suppressing properties Liu et al., 1995; Mu et al., 1996 Mu et al., , 1997 . Recently, we have shown that overexpression of PML aects the replication of some RNA virus such as VSV and in¯uenza virus, by interfering with viral mRNA and protein synthesis (Chelbi-Alix et al., 1998) . These ®nding suggest that PML could play a role in IFN-induces cell growth suppression and antiviral state.
Dierent groups have shown that PML is delocalized from NBs upon infection with several DNA viruses (reviewed in Sternsdorf et al. (1997a) . The delocalization of NBs, upon HSV-1 infection, is dependent on the expression of the viral immediateearly RING ®nger protein named ICP0 or VmW110 Maul and Everett, 1994) . ICP0 colocalizes rapidly with NBs-associated PML and Sp100 and then delocalizes them. In addition to ICP0, the cytomegalovirus IE1 protein (Korioth et al., 1996) , the Epstein-Barr-virus, EBNA5 (Szekely et al., 1996) , the adenovirus E4-ORF3 protein (Carvalho et al., 1995) , the human T cell leukaemia virus type 1 Tax oncoprotein (Desbois et al., 1996) all alter, to various extents, the localization of at least one of the NB-associated proteins. Whether such delocalization alter the level of the NBs-associated protein expression is unknown.
Here we show that HSV-1 infection leads to a rapid PML degradation without aecting its mRNA level. During HSV-1 infection, the NBs-associated Sp100 is also degraded, while SUMO-1 modi®ed protein RanGAP1 and the IFN-induced RNA-dependent protein kinase (PKR) are not. The proteasome inhibitor MG132 abrogates PML and Sp100 degradation as well as their delocalization from NBs. Thus, the well-known delocalization of PML and Sp100 from NBs upon HSV-1 infection results from their degradation.
Results

HSV-1 infection causes the decrease of PML and Sp100 proteins expression
Overexpression of PML induces resistance to infection by vesicular stomatitis virus and in¯uenza A virus (Chelbi-Alix et al., 1998) but not to infection by HSV-1 (data not shown). After HSV-1 infection, PML is rapidly delocalized from NBs (Maul et al., 1995 , but the fate of the level of the protein is unknown. U373MG cells, overexpressing PML (Figure 1a ), were infected with HSV-1 for 24 h at increasing multiplicity of infections and total protein extracts were analysed by Western blotting. No detectable PML protein was found in untreated U373MG cells, whereas three forms having apparent molecular weights in SDS ± PAGE of 90, 105 and 120 were detected in U373MG-PML ( Figure 1a) . The two higher, fainter, molecular weight species likely represent the conjugated PML-SUMO-1 forms (Muller et al., 1998; Sternsdorf et al., 1997b) . In these cells, HSV-1 infection induced PML decrease is already observed at a MOI of 0.25 (Figure 1a) . At a higher MOI, all PML forms disappeared completely ( Figure 1a ). To assess whether endogeneous PML expression is also altered, U373MG cells were treated with IFN, then infected with HSV-1. Dierent forms of PML, arising from alternative splicing of a single gene (Fagoli et al., 1992) , were induced in U373MG cells. These dierent IFN-induced PML forms, having molecular weights ranging from 70 to 130, were again decreased during HSV-1 infection in a MOI-dependent manner (Figure 1b) .
In order to detect whether the expression of another NBs-associated and IFN-induced protein is also aected, the same blot was probed with anti-Sp100 antibodies (Figure 1b) . Dierent Sp100 isoforms with apparent molecular weights ranging from 80 to 130 kDa ( Figure 1b) were induced by IFN in U373MG cells. Upon HSV-1 infection, Sp100 underwent decrease in a similar manner than to that observed for PML (Figure 1b) . In all these and the following experiments, probing the same blots with anti-actin antibodies, revealed that actin was not altered during HSV-1 infection.
We have seen so far that the MOI-dependent PML and Sp100 decrease occurred during a 24 h infection. It was of interest to know whether this is the eect of a long or short term infection or both. To address this question, cells were infected with HSV-1 at a MOI of 10 for a short period. In U373MG cells overexpressing PML, HSV-1 infection leads to PML decrease as early as 3 h post infection ( Figure 2a ). In IFN-pretreated cells, all PML isoforms expression seems to decrease entirely 4 h post HSV-1 infection (Figure 2b ). When the blot was probed with anti-Sp100 antibodies, similar decrease kinetics were observed, the higher molecular weight forms being altered ®rst at 3 h post infection, followed by a complete disappearance of all Sp100 isoforms at 6 h ( Figure 2b ). The HSV-1 induced PML and Sp100 decrease seems to be speci®c for NBsassociated proteins as the expression of RARa and the IFN-induced PKR were not altered during HSV-1 infection ( Figure 2b and data not shown).
Taken together, these experiments show that HSV-1 infection caused the alteration of the NB-associated proteins PML and Sp100 without aecting other IFNinduced proteins such as PKR.
HSV-1 infection do not alter PML mRNA level
To test if HSV-1 infection interferes with PML mRNA synthesis, U373MG cells transfected with the empty vector or overexpressing PML were infected or not with HSV-1 at a MOI of 10. After 2 or 4 h at 378C, total RNA was isolated. The RNA preparation were analysed for PML mRNA level by Northern blot Figure 3 . These PML mRNA levels were not altered during HSV-1 infection. These results suggest that the observed decrease in PML protein level is a consequence of its degradation.
The proteasome inhibitor MG132 abrogates HSV1-induced PML degradation and delocalization
The rapid HSV-1 induced PML and Sp100 decrease suggests that this might be due to proteolytic degradation occurring via a proteasome-dependent process. To test this possibility, U373MG cells overexpressing PML or treated with IFN for 2 h, were infected with HSV-1 in the presence or absence of 1 mM MG132 (carbobenzoxyl-leucinyl-leucinyl-leucinal-H, also called Z-LLL), a proteasome inhibitor (Coux et al., 1996) . The proteasome inhibitor was used in the conditions where it does not alter HSV-1 replication (data not shown). Extracts from uninfected and infected cells were analysed by Western blotting (Figure 4 and data not shown). Addition of MG132 abrogated HSV-1-induced PML degradation both in cells overexpressing PML ( Figure 4a ) and those treated with IFN ( Figure 4b ). MG132 also abrogated HSV-1-induced Sp100 degradation (data not shown). Again, the level of PKR was not altered in this experiment.
To test if MG132 also blocked HSV-1-induced NBsassociated protein delocalization, IFN-treated U373MG cells were infected with HSV-1 in the presence or absence of MG132 and stained for PML and Sp100. In the infected cells, PML and Sp100 were totally delocalized from NBs ( Figure 5 ). MG132 reduced the ability of HSV-1 to disorganize NBs, most of the cells presenting the normal nuclear punctuate pattern of PML and Sp100. The proteasome inhibitor reduced the ability of HSV-1 to disrupt NBs, thus strongly suggesting that PML and Sp100 degradation is responsible for their delocalization from NBs.
Fate of SUMO-1-conjugated proteins during HSV1-infection
A protein named PIC-1/SUMO-1 directly interacting with PML was identi®ed by using the yeast two-hybrid interaction assay (Boddy et al., 1996) . SUMO-1 has a sequence homology with ubiquitin and can be covalently linked to the nuclear pore complex associated protein, Ran GTPase-activating protein, RanGAP1 (Mahajan et al., 1997; Matunis et al., 1996) . Covalent modi®cation of PML and Sp100 by SUMO-1 has been recently reported (Muller et al., 1998; Sternsdorf et al., 1997b) . To know whether the expression of other SUMO-1 conjugated proteins is altered during HSV-1 infection, the blot presented in Figure 4b was reprobed with an anti-SUMO-1 antibodies and those presented in Figures 1b and 2a were reprobed with anti-RanGAP1 antibodies. The results (Figure 6a) show that in IFN-treated cells, many SUMO-1-conjugated proteins were degraded during HSV-1 infection, this process was blocked by MG132. Taken the number of SUMO-1 modi®ed proteins, it is unlikely that the degraded proteins are exclusively PML and Sp100. We next investigated to see whether HSV-1 infection alters the expression of the SUMO-1-conjugated protein RanGAP1, which is not known to be modulated by IFN. Two forms of RanGAP1 have been previously described, one, a 70 kDa form corresponding to the unmodi®ed RanGAP1 (localized exclusively in the cytosol) and the other a 90 kDa form is conjugated to SUMO-1 (localized in the nuclear pore complex) (Mahajan et al., 1997; Matunis et al., 1996) . Expression of RanGP1 was not aected during HSV-1 infection either in the IFNtreated cells or in those overexpressing PML (Figure 6b and c). Thus, modi®cation of RanGAP1 by SUMO-1 does not lead to its degradation during HSV-1, but this seems to modulate the subcellular localization of RanGAP1. Taken together, these results show that HSV-1 infection degrades the SUMO-1-conjugated NBs-associated proteins PML and Sp100 without aecting RanGAP1.
Discussion
The dierent biological actions of IFN are believed to be mediated by the product of speci®c cellular genes in the target cells. Three of NBs-associated proteins, PML, Sp100 and ISG20 are directly induced by IFN (Chelbi-Alix et al., 1998; Gongora et al., 1997; GroÈ tzinger et al., 1996a; Guldner et al., 1992; Lavau et al., 1995; Stadler et al., 1995) . suggesting that NBs could play a role in IFN response. PML may mediate some of the antiproliferative and antiviral activities of this cytokine, as PML has previously shown to harbour transformation and growth supressive properties Liu et al., 1995;  Mu et al., Figure 5 The proteasome inhibitor MG132 abrogated the delocalization of NBs-associated proteins during HSV-1 infection. U373MG cells were infected or not for 4 h with HSV-1 at a MOI of 10 in the absence or the presence of the proteasome inhibitor MG132 (1 mM). MG132 was added 1 h before infection. Immuno¯uorescence analysis was revealed by double staining with anti-mouse PML and anti-rabbit Sp100 antibodies Figure 6 Fate of SUMO-1-conjugated proteins during HSV-1 infection (a) Cells were treated as described in Figure 4b . The dierent cell extracts were analysed by Western blot and revealed by anti-SUMO-1 antibodies. (b) Cells were treated as described in Figure 1b . (c) Cells were treated as described in the legend to Figure 2a . The dierent cell extracts were analysed by Western blot and revealed by anti-RanGAP-1 antibodies Figure 4 The proteasome inhibitor MG132 abrogated HSV-1 induced PML degradation in cells overexpressing PML and in IFN-treated cells. U373MG PML (a) or U373MG cells treated with 1000 u/ml of IFNa for 24 h (b) were infected or not for 4 h with HSV-1 at a MOI of 10 in the absence or the presence of the proteasome inhibitor MG132 (1 mM). MG132 was added 1 h before infection. The dierent cell extracts were analysed by Western blot and revealed by anti-PML, Sp100, PKR or actin antibodies 1994) and that its overexpression confers resistance against two RNA viruses, VSV and in¯uenza virus (Chelbi-Alix et al., 1998) .
Viruses, which require the cellular machinery for their replication, have evolved dierent ways to counteract some proteins induced by IFN (reviewed in Gale and Katze (1998); Sen and Ransoho (1993) ). For example, poliovirus induces PKR degradation, in¯uenza virus induces a cellular PKR inhibitor and adenovirus VAI RNA binds PKR and prevents its activation. Earlier studies have shown that infection by HSV-1 of human cells results in the activation of PKR but the a subunit of the eIF2 is not phosphorylated and protein synthesis is unaected (Chou et al., 1995) . Moreover, it lead to the formation of 2'5' oligoadenylates analogs of as yet undetermined structures (Cayley et al., 1984) , which impair the activation of the endoribonuclease (RNase L) by authentic 2'5' oligoadenylates.
Here, we show that HSV-1 infection, without aecting PML mRNA levels, leads to inactivation of PML by decreasing its protein level in two systems: IFN-treated and PML overexpressing cells. In non infected cells, the half life of PML is greater than 6 h (Le et al., 1998; Zhu et al., 1997 and data not shown). Our demonstration that HSV-1 infection decreases PML level 3 h post-infection strongly suggests that HSV-1 aects the half life of PML, although we cannot rule out that HSV-1 infection also alters the translation of PML mRNAs. The expression of Sp100, another NBs-associated and IFN-induced protein, is also downregulated during HSV-1 infection. The HSV-1-induced PML and Sp100 degradation appears to be rapid, MOI-dependent and seems to be speci®c for NBsassociated proteins, since the expression of the IFNinduced PKR (Figures 2b and 4b ), RARa (data not shown), actin and RanGAP1 ( Figure 6) were not altered. The proteasome inhibitor reduced the ability of HSV-1 to degrade PML and Sp100 and to disrupt them from NBs. In the case of HSV-1, the immediate early gene product ICP0 was shown to be responsible for this eect Maul and Everett, 1994) . Furthermore, ICP0, which, like PML, contains a RING ®nger, rapidly associated with NBs and then disrupts PML and Sp100 localization. Our studies clarify the basis for the loss of the speckle pattern of these proteins by demonstrating that HSV-1 completely degrades PML and Sp100, most likely through ICP0 expression.
Recently, it has been shown that SUMO-1 can covalently bind to PML and Sp100 (Muller et al., 1998; Sternsdorf et al., 1997b) . PML is localized in the nucleoplasm and the nuclear matrix (Zhu et al., 1997) . Indeed, in IFN-treated cells and in cells overexpressing PML, there is a recruitment of SUMO-1 towards NBs (data not shown), suggesting that modi®ed PML is localized on NBs (Muller et al., 1998) . Conversely, during HSV-1 infections PML, Sp100 and also SUMO-1 were delocalized form NBs ( Figure 5 and data not shown). Higher molecular weigh forms of PML and Sp100, which most likely represent SUMO-1 adducts (Muller et al., 1998; Sternsdorf et al., 1997b) , were also degraded. Interestingly, ICP0 was shown to bind to HAUSP, a nuclear ubiquitin-speci®c protease of 135 kDa that partially associates with PML bodies in uninfected cells (Everett et al., 1997) . Early during HSV-1 infection, the great majority of NBs contains HAUSP, PML and ICP0 suggesting that ICP0 recruits HAUSP to NBs. Infection with a virus expressing an ICP0 mutant that fails to bind HAUSP, reduces both HAUSP recruitment onto NBs (Everett et al., 1997) and the ability of ICP0 to disturb NBs (Meredith et al., 1995) . Thus, the presence of both HAUSP and ICP0 is required for NBs distribution and most likely for PML and Sp100 degradation. Degradation of the NBsassociated proteins upon HSV-1 infection is mediated by the proteasome pathway. Indeed, in HSV-1 infected cells, inhibition of PML and Sp100 degradation by MG132 results in persistence of their NB-localization, suggesting that degradation precedes NBs delocalization. Altogether, these ®ndings suggest that during HSV-1 infection PML and Sp100 are targeted by ICP0 which recruits HAUSP onto NB leading to their degradation through the proteasome pathway.
Remarkably, SUMO-1 modi®cation of PML was shown to be triggered by arsenic trioxide (Muller et al., 1998) , leading to PML degradation (Zhu et al., 1997) . HSV-1 infection and arsenic trioxide treatment induce PML degradation by dierent pathways. Arsenic administration ®rst increases the pool of PML-SUMO-1 conjugates, leading to accumulation of PML and Sp100 on enlarged nuclear bodies (Muller et al., 1998; Zhu et al., 1997) , then to PML-SUMO-1, but not Sp100, degradation (Zhu et al., 1997 and data not shown). In contrast, HSV-1 infection degrades all PML and Sp100 forms leading to a complete loss of their staining.
Many studies have shown that early during viral infection, dierent viral proteins transiently colocalize with PML and Sp100 on NBs before disrupting them (reviewed in Sternsdorf et al., 1997a) . The functional consequences of these altered NB-antigen localization are not known. In particular, whether this is a consequence of nuclear reorganization in response to infections or a speci®c viral strategy to block cellular systems that may hamper viral replication remain to be determined. However, that the HSV-1 ICP0 , the CMV IE1 (Korioth et al., 1996) , the adenovirus E4-ORF3 proteins (Carvalho et al., 1995) , the human T cell leukaemia virus type 1 Tax oncoprotein (Desbois et al., 1996) and the lymphocytic choiomeningitis virus Z protein (Borden et al., 1998) speci®cally alter NB-associated protein localization, strongly favours this last hypothesis. It remains to be established whether in these viral infections, PML and Sp100 are also degraded or simply delocalized. Nevertheless, our demonstration that HSV-1 induces a rapid and proteasome dependent PML and Sp100 degradation provides a new example of how HSV-1 inactivates IFN-induced gene products.
Materials and methods
Cell cultures and interferon
Human glioblastoma astrocytoma U373MG, and mouse L929 cells, were grown at 378C in Dulbecco's modi®ed Eagle's medium (DMEM). Both cells were supplemented with 10% fetal calf serum. U373MG control (transfected with the empty vector) or overexpressing PML, were kept in medium supplemented with 0.5 mg/ml of G418. Recombinant human IFNa2 (10 6 international units/mg) was from Schering (USA).
Constuctoin of expression vectors and cell-lines
The complete PML cDNA on an EcoRI fragment was inserted in the bicistronic pCIN-1 vector (neomycin resistance) (Rees et al., 1996) . Stable PML-expressing U373MG clones were obtained via transfection with the pCIN-PML construct and subsequent neomycin selection (®nal concentration: 0.5 mg/ml) as previously described (Chelbi-Alix et al., 1998) . Control cells were generated in the same way using the empty vectors.
Virus stocks and cell treatments L929 cells, (2610 7 ) seeded in¯asks culture, were infected with HSV-1 at a multiplicity of infection (MOI) of 1 by absorption in 1 ml medium without serum. After 1 h, virus was removed and replaced by 10 ml of medium containing 2% serum and cells were incubated at 378C for 24 h. Cultures were then frozen and thawed three times and centrifuged to remove cellular debris. Supernatants were serially diluted and virus titers were measured by a plaque assay on L929 cells and expressed as plaque-forming units/ ml of supernatant (p.f.u./ml). These HSV-1 stocks (10 8 p.f.u./ml) were aliquoted and kept at 7808C. U373MG cells seeded in six wells were infected with HSV-1 in medium containing 2% serum at the MOI and times indicated in the Figure legends. For the proteasome inhibitor MG132 (carbobenzoxyl-leucinyl-leucinyl-leucinal-H, also called Z-LLL), cells were pretreated at 1 mM 1 h before and during infection.
Antibodies
Rabbit and mouse anti-human PML and rabbit anti-Sp100 antibodies were produced as described (Daniel et al., 1993; Puvion-Dutilleul et al., 1995) . Monoclonal anti-PKR antibodies were from Ribogene, Hayward, (CA, USA) and anti-PIC-1/SUMO1 form Zymed, (San Francisco, USA). Rabbit anti-actin antibodies were from Sigma. Rabbit anti-RanGAP1 antibodies were kindly provided by Frauke Melchoir (the Scripps Clinic, San Diego, CA, USA).
Immuno¯uourescence analysis
Cell were ®xed in 4% paraformaldehyde for 15 min at 48C. Then cells were rinsed twice in PBS and once in PBS containing 0.1% Tween-20 (PBS-Tween), incubated with primary antibodies for 1 h, washed in PBS-Tween and incubated with the appropriate secondary antibodies conjugated with either¯uorescein or Texas red. Primary antibodies were used at a dilution of 1/4000 for anti-PML, 1/500 for anti-Sp100, 1/1000 for anti-SUMO-1 and 1/100 for anti-ICP0 antibodies. After four washes in PBS, the samples were mounted in VectaShield.
Preparation of cell extracts and Western-blot analysis 10 6 cells were washed twice in PBS, scraped in 300 ml of SDS-gel loading buer and boiled for 10 min. Proteins from 40 ml of total cell extracts were separated by 10% SDS ± PAGE and transferred to nitrocellulose membranes. Membranes were blocked at room temperature for 3 h in 10% non-fat dry milk in PBS-Tween and incubated for the night at 48C with the various antibodies. The rabbit polyclonal anti-PML, anti-Sp100, anti-RanGAP1, and anti-actin antibodies were diluted respectively 1/4000, 1/ 500, 1/3000 and 1/100, and the monoclonal anti-PKR, anti-SUMO-1 antibodies were diluted respectively 1/5000 and 1/ 3000. After primary antibodies incubation, blots were washed extensively in PBS-Tween and incubated for 1 h with the appropriate peroxidase-coupled secondary antibodies (Amersham). All blots were revealed by chemoluminescence reagents (ECL. Amersham). The membranes were re-probed if necessary, for this, they were incubated in glycin 0.1 M pH 2.9 for 30 min, washed twice in PBSTween and then blocked and incubated as described.
Northern blot analysis
Total RNA were extracted with a Bioprobe Systems RNA extraction Kit Standard. After blotting on nitrocellulose membranes (Scheicher & Schuell), Northern blot analysis was performed with random priming (Boehringer Mannhein) radiolabelled EcoRI PML fragment or GAPDH as probes.
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